Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 36-4362105 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Canavan disease medical Research in the fields of stem cell, dna, gene therapy, and pharmacological therapy.
Principal Officer
Ilyce J Randell
Total Revenue
$12K
FY2024
Total Expenses
$37K
FY2024
Net Assets
$102K
Program Ratio
91.4%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.